You Are Invited to a LIVE CME/CPE/CNE Webcast:The Multiple Myeloma Treatment Paradigm: Addressing an Evolving and Multifaceted Process Live Webcast Live Webcast Dates
|
||||||||||||||
Click here to download the slides from this webcast series. |
||||||||||||||
CUTTING EDGE TOPICS | ||||||||||||||
| ||||||||||||||
EXPERT FACULTY | ||||||||||||||
| ||||||||||||||
WHO SHOULD ATTEND? | ||||||||||||||
| ||||||||||||||
PROGRAM OVERVIEW | ||||||||||||||
The management of multiple myeloma (MM) is a priority area for MCOs in order to optimize clinically- and economically-appropriate care for their members. As novel agents become available, treatment decision making is becoming more complex and MCOs and other payer organizations need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. Guidance is needed for the target audience to implement current guidelines, utilize clinical pathways, design appropriate medical and pharmacy benefits, and implement effective specialty pharmacy management services. This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients with MM. Multidisciplinary faculty will be utilized featuring a managed care medical director, a pharmacy director, and a hematology/oncology expert. | ||||||||||||||
EDUCATIONAL OBJECTIVES | ||||||||||||||
After completing the activity, participants should be better able to:
|
||||||||||||||
AGENDA | ||||||||||||||
|
||||||||||||||
ACCREDITATION INFORMATION | ||||||||||||||
Joint Accreditation Statement | ||||||||||||||
| ||||||||||||||
Physician Continuing Medical Education The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Pharmacy Education | ||||||||||||||
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008162-9999-18-262-L01-P Type of Activity: Application For Pharmacists: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to the CPE Monitor as required. After receipt of a completed activity evaluation form, you will be provided with instructions to have your credit immediately uploaded to the CPE Monitor. Continuing Nursing Education The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Interprofessional Continuing Education
|
||||||||||||||
Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. Hardware/Software Requirements Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up. Fee Information There is no fee for this educational activity. Policy on Privacy and Confidentiality Please see final activity for the policy on privacy and confidentiality that relates to this internet activity. If you have any questions, please call (215) 619-8812 or email info@impactedu.net. |